Dataset Information


Proteasomal regulation of caspase-8 in cancer cell apoptosis.

ABSTRACT: Previous studies demonstrated that proteasome inhibition sensitizes TRAIL resistant prostate cancer cells to TRAIL-mediated apoptosis via stabilization of the active p18 subunit of caspase-8. The present study investigated the impact of proteasome inhibition on caspase-8 stability, ubiquitination, trafficking, and activation in cancer cells. Using caspase-8 deficient neuroblastoma (NB7) cells for reconstituting non-cleavable mutant forms of caspase-8, we demonstrated that the non-cleavable forms of caspase-8 are capable of inducing apoptosis comparably to wild-type caspase-8, in response to proteasome inhibitor and GST-TRAIL. Moreover in the LNCaP human prostate cancer cells, caspase-8 polyubiquitination occurs after TRAIL stimulation and caspase-8 processing. Subcellular fractionation analysis revealed caspase-8 activity in both cytosol and plasma membrane fractions in both NB7 reconstituted caspase-8 cell lines, as well the LNCaP prostate cancer cells. The present results suggest that caspase-8 stabilization through proteasome inhibition leads to reactivation of the extrinsic pathway of apoptosis and identify E3 ligase mediating caspase-8 polyubiquitination, as a novel molecular target. Inhibition of this E3 ligase in combination with TRAIL towards restoring apoptosis signaling activation may have potential therapeutic significance in resistant tumors.

PROVIDER: S-EPMC3762601 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5709619 | BioStudies
| S-EPMC8738721 | BioStudies
| S-EPMC3632452 | BioStudies
| S-EPMC3674381 | BioStudies
| S-EPMC3340270 | BioStudies
| S-EPMC3676898 | BioStudies
| S-EPMC1361275 | BioStudies
2012-01-01 | S-EPMC3734984 | BioStudies
| S-EPMC4626104 | BioStudies
| S-EPMC3354650 | BioStudies